Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05094791 · ClinicalTrials.gov registry record
Lateralization After IntraMedullary Nailing of InterTrochanteric Hip Fractures, Clinical and Radiographic Outcomes
A clinical trial, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- 60
- Enrollment target
NCT05094791: Completed study, sponsored by Prisma Health-Upstate.
NCT05094791 is a clinical trial that has completed, run by Prisma Health-Upstate. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05094791 has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Intertrochanteric fractures are commonly stabilized using an intramedullary nail with a lag screw that enters the lateral cortex of the femur. This lag screw commonly protrudes during the healing process and may cause implant related pain. This study will help determine if implant related pain is different depending to the lag screw design.
Primary Outcome
Pain will be accessed at the location of the lag screw, pain will be measured by using a Numeric rating scale (0-100)
Interventions
- DEVICE Telescoping Lag Screw
- DEVICE Standard lag Screw
- DEVICE Standard lag screw with addition of worm screw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2024-02-23 |
What the finished NCT05094791 record still lists
NCT05094791 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Telescoping Lag Screw is the first listed.
NCT05094791 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05094791 about?
NCT05094791 is a clinical study titled "Lateralization After IntraMedullary Nailing of InterTrochanteric Hip Fractures, Clinical and Radiographic Outcomes". Intertrochanteric fractures are commonly stabilized using an intramedullary nail with a lag screw that enters the lateral cortex of the femur. This lag screw commonly protrudes during the healing process and may cause implant related pain. This study will help determine if implant related pain is di...
What is the current status of trial NCT05094791?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-10-04. Estimated completion is 2024-02-23.
What interventions are being tested in trial NCT05094791?
The interventions under investigation include: Telescoping Lag Screw (DEVICE), Standard lag Screw (DEVICE), Standard lag screw with addition of worm screw (DEVICE).
Who is sponsoring clinical trial NCT05094791?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI